Skip to main content

Year: 2020

Ricky Sitomer, CEO of Star Jets International, Inc. (JETR), Announces Record $3,000,000+ in Revenue for the Third Quarter of 2020

NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) — Star Jets International, Inc. (OTCPink: JETR), a leading Private Jet Charter Company, announces that the Company booked in excess of $3,000,000 million for the third quarter of 2020; an increase in sales from the same quarter last year of 245%. The global Covid-19 pandemic increased revenue, as predicted, because Company continues on a tremendous growth trend as the demand for private air travel shows no signs of slowing down.The Company expects to continue increasing its bookings throughout the 2020 Holiday season in the 4th quarter and into the 1st quarter of 2021. Health concerns related to Covid-19 continue to remain a primary reason for the uptick in private travel demand.Ricky Sitomer, CEO of JETR stated, “We are very excited to have increased our revenue this quarter to over $3,000,000....

Continue reading

Aptean to Add Product Lifecycle Management to its Solution Suite Through Acquisition of Lascom

ALPHARETTA, Ga., Nov. 24, 2020 (GLOBE NEWSWIRE) — Today, Aptean, a global provider of mission-critical enterprise software solutions, announced the signing of a definitive agreement to acquire Lascom, a leader in product lifecycle management (PLM) solutions for the manufacturing sector, including companies in the food and beverage, personal care, cosmetics and retail industries. Through this acquisition, Aptean will expand its cloud-native solution offerings to complement its enterprise resource planning (ERP) leadership and build on its growing presence in Europe. The transaction is expected to close in the fourth quarter of 2020, pending customary closing conditions.Lascom was founded in 1989 and is headquartered in Velizy, France with its U.S. operations located in San Diego, California. The company’s cloud-native PLM software...

Continue reading

Aptean ajoute une offre « Product Lifecycle Management » à son portefeuille de solutions avec l’acquisition de Lascom

ALPHARETTA, Ga., 24 nov. 2020 (GLOBE NEWSWIRE) — Aujourd’hui, Aptean, un acteur mondial des logiciels d’entreprise, a annoncé la signature d’un accord définitif pour l’acquisition de Lascom, un précurseur des solutions de gestion du cycle de vie des produits (PLM) pour les industriels, en particulier dans le secteur du food et beverage, de la cosmétique et de la distribution. Grâce à cette acquisition, Aptean complète son offre de solutions « cloud-natives » pour asseoir son leadership sur les Enterprise Resource Planning (ERP) et accélérer sa présence en Europe. La transaction devrait être conclue au quatrième trimestre de 2020, une fois levées les conditions de clôture habituelles.La société Lascom, basée à Vélizy en France, a été fondé en 1989 et adresse le marché américain depuis une filiale située à San Diego, en...

Continue reading

Nabis Holdings Inc. gibt Rekapitalisierungstransaktion mit Unterstützung der wichtigsten Stakeholder bekannt

VANCOUVER, British Columbia, Nov. 24, 2020 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) („Nabis“ oder das „Unternehmen“) gab heute den Abschluss eines Unterstützungsvertrags (der „Unterstützungsvertrag“) mit bestimmten Inhabern (die „Anleihegläubiger“) des ausstehenden Kapitalbetrags von 35 Millionen USD aus den mit 8,0% verzinsten ungesicherten Wandelschuldverschreibungen des Unternehmens (die „Schuldverschreibungen“) bekannt. Gemäß dem Unterstützungsvertrag haben die Inhaber der Schuldverschreibungen zugestimmt, einen Rekapitalisierungsplan für Nabis mitzutragen, der – vorbehaltlich der erforderlichen Zustimmung der Gläubiger (die „Gläubiger“) von Nabis und des Ontario Superior Court of Justice – zur Rekapitalisierung der Schuldverschreibungen und aller anderen Schulden des Unternehmens (die „Rekapitalisierung“)...

Continue reading

Genmab Announces Enapotamab Vedotin Update

Company AnnouncementGenmab will not advance the development of enapotamab vedotinData from expansion cohorts did not meet stringent criteria for proof-of-conceptGenmab to prioritize development of other innovative product candidatesCopenhagen, Denmark; November 24, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that it will not advance the development of enapotamab vedotin. While enapotamab vedotin has shown some evidence of clinical activity, this was not optimized by different dose schedules and/or predictive biomarkers. Accordingly, the data from the expansion cohorts did not meet Genmab’s stringent criteria for proof-of-concept.“We are committed to developing innovative antibody products for patients with cancer, however the data from the enapotamab vedotin expansion cohorts unfortunately does not support moving this product candidate...

Continue reading

Twelve Vacant Lots Available for Purchase in Private Island Community in Pensacola, FL

PENSACOLA, Fla., Nov. 24, 2020 (GLOBE NEWSWIRE) — Escambia County, FL is selling 12 vacant lots of residential real estate on Innerarity Island, located within Pensacola, Florida. The vacant lots are located inside an established gated community and consist of a water view lot and interior lots. All lots are currently uninhabited. These properties will be up for auction exclusively on GovDeals.com until December 1, 2020. GovDeals.com, a leading marketplace in surplus solutions, offers a platform for state and local agencies to sell their surplus and seized items over the internet to bidders and buyers around the world.Innerarity Island, located in Northwest Florida, is a private island community near Perdido Key, Florida. The single entrance to the island is located just off State Road 292 on Innerarity Point Road, just before the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.